5.9 C
New York
Friday, March 29, 2024

Benzinga’s Top Upgrades, Downgrades For August 29, 2017

Courtesy of Benzinga.

Top Upgrades

  • Wedbush upgraded Kite Pharma Inc (NASDAQ: KITE) from Underperform to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Wedbush upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Neutral to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.
  • Bank of America upgraded Heico Corp (NYSE: HEI) from Neutral to Buy. HEICO shares dropped 1.30 percent to close at $83.25 on Monday.
  • Analysts at Raymond James upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Market Perform to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.




Top Downgrades

  • Analysts at FBR Capital downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Neutral. Finish Line shares fell 29.6 percent to $7.34 in pre-market trading.
  • Canaccord Genuity downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Chardan Capital downgraded Intellia Therapeutics Inc (NASDAQ: NTLA) from Buy to Neutral. Intellia Therapeutics shares dropped 2.45 percent to $20.31 in pre-market trading.
  • Axiom Capital downgraded JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Hold to Sell. JA Solar shares closed at $6.38 on Monday.
  • BTIG downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
  • Analysts at Bank of America downgraded Cemex SAB de CV (ADR) (NYSE: CX) from Buy to Neutral. Cemex shares fell 0.11 percent to close at $9.12 on Monday.
  • JMP Securities downgraded Loxo Oncology Inc (NASDAQ: LOXO) from Market Outperform to Market Perform. Loxo Oncology shares rose 5.89 percent to close at $78.56 on Monday.
  • SunTrust Robinson Humphrey downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.

 




Top Initiations

 

  • Analysts at Macquarie initiated coverage on Carter’s, Inc. (NASDAQ: CRI) with an Outperform rating. Carter’s shares closed at $85.92 on Monday.
  • Brean Capital initiated coverage on CenterState Banks Inc (NASDAQ: CSFL) with a Hold rating. CenterState Banks shares closed at $24.73 on Monday.
  • Nomura initiated coverage on AveXis Inc (NASDAQ: AVXS) with a Reduce rating. The price target for AveXis is set to $52. AveXis shares closed at $96.98 on Monday.
  • Analysts at Chardan Capital initiated coverage on Tivity Health Inc (NASDAQ: TVTY) with a Neutral rating. The price target for Tivity Health is set to $40. Tivity Health shares closed at $37.55 on Monday.
  • KLR Group initiated coverage on Ultra Petroleum Corp. (NYSE: UPL) with a Buy rating. The price target for Ultra Petroleum is set to $14. Ultra Petroleum shares closed at $7.61 on Monday.
  • Analysts at Citi initiated coverage of Venator Materials PLC (NYSE: VNTR) with a Buy rating. The price target for Venator Materials is set to $24. Venator Materials shares closed at $20.05 on Monday.
  • Analysts at Aegis Capital initiated coverage on DarioHealth Corp (NASDAQ: DRIO) with a Buy rating. The price target for DarioHealth is set to $3.50. DarioHealth shares closed at $2.00 on Monday.
  • Bank of America initiated coverage on Helen of Troy Limited (NASDAQ: HELE) with an Underperform rating. The price target for Helen of Troy is set to $87. Helen of Troy shares closed at $96.85 on Monday.

Latest Ratings for KITE

Date Firm Action From To
Aug 2017 Wedbush Upgrades Underperform Neutral
Aug 2017 Canaccord Genuity Downgrades Buy Hold
Aug 2017 SunTrust Robinson Humphrey Downgrades Buy Hold

View More Analyst Ratings for KITE


View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,449FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x